Log In
BCIQ
Print this Print this
 

Interleukin-12 (IL-12)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Interleukin-12 (IL-12)

BCIQ
Print ChartPrint this
0 1 0 0 1 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 2 1 4 3 0 0 1 2 0 0 1 1 1
Phases of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPhase IIIMarketed
Autoimmune

1

2

0

0

1

1

1

Cancer

0

2

1

4

3

0

0

Endocrine / Metabolic

0

1

0

0

0

0

0

Hepatic

0

0

0

0

1

0

0

Inflammation

0

1

0

0

1

0

0




 Products Targeting Interleukin-12 (IL-12)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

7

$167.6M

$3.4M

$30.4M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today